Market Access Enablement Strategies, Part 2: Navigating Policy and Marketplace Developments

Avalere Essential Voice

English - September 24, 2020 14:17 - 1 hour - 83.2 MB
Medicine Health & Fitness Science Life Sciences Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 2020 Election with Avalere: What Are the Drug Pricing Policies?

Next Episode: 2020 Election with Avalere: First Presidential Debate Healthcare Recap

Tune in to the replay of Part 2 of our Avalere Market Access Enablement Strategies webinar series to learn about the policy changes and market factors that could impact the future relationships between manufacturers, health plans, and pharmacy benefit managers.

Recent pricing and policy developments may create major shifts in plan design and preparation. Join our policy and market access experts to evaluate forward-leaning considerations and perspectives for how to best prepare for these developments and adapt your business strategies.

Key Topics Executive orders related to drug pricing (e.g., rebate rule, importation, international pricing index, 340B) State-level regulation and legislation CMS’s proposed value-based purchasing rule: possible impact on manufacturers, healthcare plans, and PBMs COVID-19 impacts and coverage shifts

This webinar was recorded on September 22, 2020.